Poolbeg Pharma PLC (LSE: POLB) is a clinical-stage biopharma company focused on infectious disease and immunotherapy. With a capital-light model, Poolbeg in-licenses promising candidates and develops them to early clinical stages. Its portfolio includes influenza, oncology, and long-COVID assets, targeting high-impact unmet needs.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.